EUVIMEDEUVIMED entdecken
Crossref

Pattern of a Serum Biomarker Panel in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients – A Single Center Study From Low/Middle Income Country

Mona Fakhry iD, Ahmed Elhemaly iD, Mahmoud Hammad iD, Ghada M Al-Toukhy iD, M T Mansour, Alaa Elhaddad iD

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Mona Fakhry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Biomarkers, Graft vs Host Disease. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allogenic hematopoietic stem cell transplantation is compromised by transplant‐related morbidity and mortality, particularly acute graft‐versus‐host disease (aGVHD). Early diagnosis or prediction of aGVHD is crucial for improving treatment outcomes. This study aimed to explore the utility of a biomarker panel for predicting and diagnosing aGVHD, as well as correlating biomarkers with aGVHD severity and response to treatment.

Methods

In this prospective study of 83 pediatric patients undergoing allogeneic HSCT, patterns of seven biomarkers were followed starting from the day of stem cell infusion up to day 90 post‐transplant.

Results

Patients with aGVHD exhibited significantly higher levels of IL‐2Rα, IL‐6, IL‐8, and HGF at the onset of aGVHD. Furthermore, patients with refractory aGVHD demonstrated elevated levels of HGF on day 28 post‐transplant. In aGVHD patients, the biomarkers exhibited a distinct pattern. With the exception of IL‐6, all biomarkers significantly increased at the onset of aGVHD. Following treatment, most biomarker levels decreased, except IL‐6, IL‐8, and HGF, which remained elevated 28 days post therapy initiation. These three biomarkers were also significantly higher in steroid‐refractory patients.

Conclusion

In summary, IL‐2Rα, IL‐6, IL‐8, and HGF show potential for aiding in the diagnosis of aGVHD. Additionally, HGF, IL‐6, and IL‐8 levels may serve as predictors of response to steroid therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationBiomarkersGraft vs Host DiseaseHumansMaleFemaleChildProspective StudiesChild, PreschoolAdolescentInfantHepatocyte Growth FactorTransplantation, HomologousDeveloping Countries

Stichwörter der Autor:innen

Allo‐HSCTHGFIL‐6acute GVHDbiomarkers

Substanzen

BiomarkersHepatocyte Growth FactorHGF protein, human

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt.
  • Department of Pediatric Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
  • Virology and Immunology Department, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt.
  • Virology and Immunology Department, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.

ORCID-Profile: Mona Fakhry, Ahmed Elhemaly, Mahmoud Hammad, Ghada M Al-Toukhy, Alaa Elhaddad

Zitieren

APA

Fakhry, M., Elhemaly, A., Hammad, M., Al-Toukhy, G. M., Mansour, M. T., & Elhaddad, A. (2025). Pattern of a Serum Biomarker Panel in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients – A Single Center Study From Low/Middle Income Country. Pediatric Transplantation. https://doi.org/10.1111/petr.70211

Vancouver

Fakhry M, Elhemaly A, Hammad M, Al-Toukhy GM, Mansour MT, Elhaddad A. Pattern of a Serum Biomarker Panel in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients – A Single Center Study From Low/Middle Income Country. Pediatric Transplantation. 2025. doi:10.1111/petr.70211

BibTeX
@article{Fakhry2025,
  author = {Fakhry, Mona and Elhemaly, Ahmed and Hammad, Mahmoud and Al-Toukhy, Ghada M and Mansour, M T and Elhaddad, Alaa},
  title = {Pattern of a Serum Biomarker Panel in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients – A Single Center Study From Low/Middle Income Country},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70211}
}
Kostenlos starten →